头孢洛林 (Chinese Wikipedia)
Analysis of information sources in references of the Wikipedia article "头孢洛林" in Chinese language version.
refsWebsite
Global rank
Chinese rank
1st place
1st place
low place
low place
911th place
1,176th place
doi.org
- Kanafani ZA, Corey GR. Ceftaroline: a cephalosporin with expanded Gram-positive activity. Future Microbiology. February 2009, 4: 25–33 [2011-07-12]. PMID 19207097. doi:10.2217/17460913.4.1.25. （原始内容存档于2019-12-08）.
- Villegas-Estrada A, Lee M, Hesek D, Vakulenko SB, Mobashery S. Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics. Journal of the American Chemical Society. July 2008, 130 (29): 9212–3. PMC 2747592
. PMID 18582062. doi:10.1021/ja8029448. - Zhanel GG, Sniezek G, Schweizer F, Zelenitsky S, Lagacé-Wiens PR, Rubinstein E, Gin AS, Hoban DJ, Karlowsky JA. Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus. Drugs. 2009, 69 (7): 809–31. PMID 19441869. doi:10.2165/00003495-200969070-00003.
- Yukihiro I, Junko B. Stability and Stabilization Studies of TAK-599 (Ceftaroline Fosamil) a Novel N-Phosphono Type Prodrug of Anti-methicillin Resistant Staphylococcus aureus Cephalosporin T-91825. Chem Pharm Bull. 2008, 56 (10): 1406–11 [2011-07-12]. PMID 18827379. doi:10.1248/cpb.56.1406. （原始内容存档于2019-06-29）.
drugs.com
- New Drug Approvals. 2010-10-29 [2010-11-08]. （原始内容存档于2010-11-28）.
- Teflaro. 2010-10-29 [2010-11-08]. （原始内容存档于2017-07-18）.
frx.com
- Forest Announces FDA Approval of Teflaro(TM) (ceftaroline fosamil) for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection (新闻稿). Forest Laboratories. 2010-10-29 [October 30, 2010]. （原始内容存档于2011-09-28）.
futuremedicine.com
- Kanafani ZA, Corey GR. Ceftaroline: a cephalosporin with expanded Gram-positive activity. Future Microbiology. February 2009, 4: 25–33 [2011-07-12]. PMID 19207097. doi:10.2217/17460913.4.1.25. （原始内容存档于2019-12-08）.
ibtimes.com
- FDA approves Teflaro for treatment of bacterial infections. 30 Oct 2010 [2011-07-12]. （原始内容存档于2010-11-04）.
jst.go.jp
jstage.jst.go.jp
- Yukihiro I, Junko B. Stability and Stabilization Studies of TAK-599 (Ceftaroline Fosamil) a Novel N-Phosphono Type Prodrug of Anti-methicillin Resistant Staphylococcus aureus Cephalosporin T-91825. Chem Pharm Bull. 2008, 56 (10): 1406–11 [2011-07-12]. PMID 18827379. doi:10.1248/cpb.56.1406. （原始内容存档于2019-06-29）.
nih.gov
ncbi.nlm.nih.gov
- Kollef MH. New antimicrobial agents for methicillin-resistant Staphylococcus aureus. Crit Care Resusc. December 2009, 11 (4): 282–6. PMID 20001879.
- Kanafani ZA, Corey GR. Ceftaroline: a cephalosporin with expanded Gram-positive activity. Future Microbiology. February 2009, 4: 25–33 [2011-07-12]. PMID 19207097. doi:10.2217/17460913.4.1.25. （原始内容存档于2019-12-08）.
- Parish D, Scheinfeld N. Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection. Current Opinion in Investigational Drugs (London, England : 2000). February 2008, 9 (2): 201–9. PMID 18246523.
- Villegas-Estrada A, Lee M, Hesek D, Vakulenko SB, Mobashery S. Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics. Journal of the American Chemical Society. July 2008, 130 (29): 9212–3. PMC 2747592 . PMID 18582062. doi:10.1021/ja8029448.
- Zhanel GG, Sniezek G, Schweizer F, Zelenitsky S, Lagacé-Wiens PR, Rubinstein E, Gin AS, Hoban DJ, Karlowsky JA. Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus. Drugs. 2009, 69 (7): 809–31. PMID 19441869. doi:10.2165/00003495-200969070-00003.
- Yukihiro I, Junko B. Stability and Stabilization Studies of TAK-599 (Ceftaroline Fosamil) a Novel N-Phosphono Type Prodrug of Anti-methicillin Resistant Staphylococcus aureus Cephalosporin T-91825. Chem Pharm Bull. 2008, 56 (10): 1406–11 [2011-07-12]. PMID 18827379. doi:10.1248/cpb.56.1406. （原始内容存档于2019-06-29）.
- Ishikawa t, Nobuyuki M; et al. TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: Synthesis, physicochemical and pharmacological properties. Bioorg Med Chem. 2003, 11 (11): 2427–2437. PMID 12735989.
web.archive.org
- Kanafani ZA, Corey GR. Ceftaroline: a cephalosporin with expanded Gram-positive activity. Future Microbiology. February 2009, 4: 25–33 [2011-07-12]. PMID 19207097. doi:10.2217/17460913.4.1.25. （原始内容存档于2019-12-08）.
- Forest Announces FDA Approval of Teflaro(TM) (ceftaroline fosamil) for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection (新闻稿). Forest Laboratories. 2010-10-29 [October 30, 2010]. （原始内容存档于2011-09-28）.
- New Drug Approvals. 2010-10-29 [2010-11-08]. （原始内容存档于2010-11-28）.
- FDA approves Teflaro for treatment of bacterial infections. 30 Oct 2010 [2011-07-12]. （原始内容存档于2010-11-04）.
- Teflaro. 2010-10-29 [2010-11-08]. （原始内容存档于2017-07-18）.
- Yukihiro I, Junko B. Stability and Stabilization Studies of TAK-599 (Ceftaroline Fosamil) a Novel N-Phosphono Type Prodrug of Anti-methicillin Resistant Staphylococcus aureus Cephalosporin T-91825. Chem Pharm Bull. 2008, 56 (10): 1406–11 [2011-07-12]. PMID 18827379. doi:10.1248/cpb.56.1406. （原始内容存档于2019-06-29）.